Learn More About Our ResearchA Simple Blood Test Could Save Lives
Researchers from St. Joseph’s Healthcare Hamilton recently took part in a study which determined that a simple blood test can predict heart attack for up to 30 days after surgery. This article was featured in the January-February 2013 issue of Connections.
Research Makes Drug-Free Menopause Relief A Reality
Staff members within the Women's Health Concerns Clinic and the Anxiety Treatment and Research Centre have authored a workbook which guides women through the use of cognitive and behavioural techniques to relieve menopausal symptoms. This article was featured in the November 2012 issue of Connections.
Biostatistics Unit Seeks Internal Partners
Do you need assitance with your research? The Biostatistics Unit offers statistical support tailored to the ongoing needs of SJHH researchers. This article was featured in the September 2012 issue of Connections.
Launch of Research Happens
Research Administration is proud to announce the launch of an internal marketing campaign that aims to bring research to the forefront of the SJHH community. This article was featured in the June/July 2012 issue of Connections.
Co-authors Drs Mark Crowther and Wendy Lee research on immune Thrombocytopenia (blood disorders) guidelines. Dr. Lee speaks to their research on CHCH News on February 2, 2012.
Annual September Epidemic for Asthma Sufferers
Professor Neil Johnston, Epidemiologist at the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton explains some of the reasons why the number of problems increase in September for asthma sufferers.
Dr. Nader Khalidi , Staff Rheumatologist at SJHH speaks with CHCH News on August 17, 2011 regarding Vasculitis, which is an inflammation of the vasculature (blood vessels), including the arteries and/or the veins.
Fecal Transplantation and C. difficile at SJHH
Dr. Christine Lee, Medical Director for Infection Prevention and Control at St. Joseph's Healthcare Hamilton speaks with Canada AM on July 11, 2011 regarding the potential treatment to restore healthy bacteria in the colon so patients can combat the desease-producing Clostridium difficiile.
Test developed by Hamilton Virologist receives FDA approval in the U.S.
The U.S. Food and Drug Administration (FDA) has approved the use of a new test developed by Virologist Dr. James Mahony, Director of the McMaster University Regional Virology and Chlamydiology Laboratory at St. Joseph's Healthcare Hamilton. The test, xTAGTM Respiratory Viral Panel (RVP), was developed in conjunction with Luminex Molecular Diagnostics (formerly TM Biosciences) and simultaneously detects some of the most prevalent respiratory viruses, including the flu and the common cold, helping doctors more accurately diagnose patients.
Targeting anemia with erythropoietin during critical illness
New England Journal of Medicine article by Drs. Deborah Cook and Mark Crowther